Unit 4 - Receptors as Drug targets Flashcards
Where are most receptors found?
Embedded within the cell membrane with part of their structure exposed on the outer surface and part exposed on the inner surface
What do receptors interact with?
Chemical messengers outside the cell
- transmit their message to the inside of the cell
What are the two categories of chemical messengers?
Neurotransmitters - released from nerve cells - neurones Hormones - released from glands
What is an endogenous ligand?
Natural chemical messenger which binds to a specific protein receptor which recognises that particular messenger
What is signal transduction?
The endogenous ligand bind in a binding domain that is exposed on the outer surface of the cell, causing a change in shape which triggers a series of further events affecting other proteins within the cell membrane and the cell cytoplasm
What happens to the binding domain once the message has been received?
The endogenous ligand leaves the binding domain unchanged and the protein returns to its inactive conformation or shape
What effect does a full agonist have?
Produces maximal biological response
Has maximal positive intrinsic activity
- efficacy
What effect does a partial agonist have?
Produces partial maximal biological response compared with full agonist
Has lower efficacy
What effect does an inverse agonist have?
Produces opposite biological response of the endogenous ligand
Negative efficacy
What is a competitive receptor antagonist?
Binds to a receptor at the same site as an endogenous or pharmacological agonist
- blocking agonist binding
- blocking receptor activation
Do not affect agonist activity
- maximal response
Do decrease affinity and potency
Can be reversed by increasing the amount of agonist
What is a non-competitive receptor antagonist?
Bind to the same site as the agonist
Generally irreversible owing to formation of a covalent bond between antagonist and receptor
Reduce the number of receptors available to the agonist
What are allosteric non-competitive receptor antagonists?
Drug binds to an allosteric site on the receptor
- different from where an agonist binds
- primary site
Binding to the allosteric site modifies the conformation of the primary sit
- altered conformation is less responsive to the agonist
What methods are used to help design agonist and antagonists?
X-ray structure of protein-ligand complex Ligand Based Drug Design - LBDD Structure Based Drug Design - SBDD Computer Aided Drug Design - CADD
What is Ligand Based Drug Design?
Don’t know receptor structure
Know ligands
What is Structure Based Drug Design?
Know receptor structure
Don’t know ligands